EUVIMEDEUVIMED entdecken
Crossref

FKBP5 Methylation in Adrenal Insufficiency: New Insights Into Assessing the Quality of Glucocorticoid Replacement

Irina Chifu iD, Anna-Lena Richter, Juliane Lippert, Mario Detomas iD, Carolin Scheuermann, Sabine Herterich, Birgit Harbeck, Janik Freytag, Barbara Altieri iD, Stefanie Hahner

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Irina Chifu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Division of Endocrinology and Diabetology, University Hospital of Würzburg, University of Würzburg, Würzburg 97080…. Hauptthemen laut MEDLINE: Adrenal Insufficiency, Tacrolimus Binding Proteins, DNA Methylation, Glucocorticoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Methylation of FKBP5, a glucocorticoid (GC)-receptor co-chaperone, negatively correlates with cortisol levels in both healthy individuals and Cushing patients, potentially serving as an indicator of GC exposure.

Objective

We explored whether GC replacement correlates with FKBP5 methylation in patients with adrenal insufficiency (AI), aiming to assess the adequacy of therapy.

Methods

In an explorative cross-sectional analysis, we analyzed FKBP5 gene methylation at 54 CpG sites using bisulfite pyrosequencing in 120 patients with chronic primary (n = 72) and secondary (n = 48) AI on hydrocortisone replacement. Results were correlated with GC replacement, salivary cortisol, 24-hour urinary cortisol, FKBP5 polymorphisms, physician-guided therapy adjustments, and a predefined clinical score for assessment of GC exposure. Methylation levels were further compared with patients with cortisol-producing adrenal adenomas (CPA, n = 64).

Results

Significant negative correlations were found between methylation levels and GC dose, clinical GC replacement score, and salivary and urinary cortisol levels. Patients advised to increase their GC dose showed higher methylation levels than those recommended to reduce or maintain their dose. AI patients exhibited similar or lower methylation levels compared to those with CPA.

Conclusion

The correlation between FKBP5 methylation status, GC replacement dose, and clinical evaluation of therapy suggests a dose-dependent effect of GC replacement on FKBP5 methylation. This encourages further research into the added value of FKBP5 methylation analysis in assessing the quality of replacement therapy. The lower methylation levels in AI compared to CPA suggest a potential impact of the cortisol peaks arising under conventional GC treatment on FKBP5-methylation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal InsufficiencyTacrolimus Binding ProteinsDNA MethylationGlucocorticoidsHormone Replacement TherapyHumansFemaleMaleMiddle AgedCross-Sectional StudiesAdultHydrocortisoneSalivaAged

Stichwörter der Autor:innen

FKBP5adrenal insufficiencyglucocorticoid replacementmethylation

Substanzen

Tacrolimus Binding ProteinsGlucocorticoidsHydrocortisone

Autor:innen und Institutionen

  • Department of Internal Medicine I, Division of Endocrinology and Diabetology, University Hospital of Würzburg, University of Würzburg, Würzburg 97080, Germany.
  • Clinical Chemistry and Laboratory Medicine, University Hospital of Wuerzburg, Wuerzburg 97080, Germany.
  • III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.
  • MVZ Amedes Experts, Endocrinology, Hamburg 20095, Germany.

ORCID-Profile: Irina Chifu, Mario Detomas, Barbara Altieri

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Chifu, I., Richter, A. L., Lippert, J., Detomas, M., Scheuermann, C., Herterich, S., Harbeck, B., Freytag, J., Altieri, B., & Hahner, S. (2026). FKBP5 Methylation in Adrenal Insufficiency: New Insights Into Assessing the Quality of Glucocorticoid Replacement. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf383

Vancouver

Chifu I, Richter AL, Lippert J, Detomas M, Scheuermann C, Herterich S, et al. FKBP5 Methylation in Adrenal Insufficiency: New Insights Into Assessing the Quality of Glucocorticoid Replacement. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf383

BibTeX
@article{Chifu2026,
  author = {Chifu, Irina and Richter, Anna-Lena and Lippert, Juliane and Detomas, Mario and Scheuermann, Carolin and Herterich, Sabine and Harbeck, Birgit and Freytag, Janik and Altieri, Barbara and Hahner, Stefanie},
  title = {FKBP5 Methylation in Adrenal Insufficiency: New Insights Into Assessing the Quality of Glucocorticoid Replacement},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf383}
}
Kostenlos starten →